Actinium Pharmaceuticals Inc. (ATNM)
NYSE · Healthcare
Actinium Pharmaceuticals Inc. Income Statement 2010–2025
| Dec 2025 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 90,000 | 81,000 | 1.0M | 1.1M | 0 | 0 |
| Gross Profit | — | — | — | 244,000 | 0 | 0 |
| Profitability | ||||||
| Operating Income | -36.2M | -51.9M | -34.1M | -25.0M | -3.3M | -26,053 |
| EBITDA | -36.1M | -51.7M | -33.4M | -24.4M | -3.3M | — |
| Net Income | -33.9M | -48.8M | -33.0M | -24.8M | -3.4M | -467,266 |
| Per Share Data | ||||||
| EPS (diluted) | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 31M | 27M | 24M | 21M | 14M | 11M |
Actinium Pharmaceuticals Inc. Income Statement — FAQ
Actinium Pharmaceuticals Inc. (ATNM) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ATNM's income statement history?
The chart and table above show Actinium Pharmaceuticals Inc.'s income statement by year and by quarter, including the growth rate.